Early activation of IKK␤ during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 280: H1264-H1271, 2001.-We have demonstrated that in vitro brief ischemia activates nuclear factor (NF)-B in rat myocardium. We report in vivo ischemia-reperfusion (I/R)-induced NF-B activation, IB kinase -␤ (IKK␤) activity, and IB␣ phosphorylation and degradation in rat myocardium. Rat hearts were subjected to occlusion of the coronary artery for up to 45 min or occlusion for 15 min followed by reperfusion for up to 3 h. Cytoplasmic and nuclear proteins were isolated from ischemic and nonischemic areas of each heart. NF-B activation was increased in the ischemic area (680%) after 10 min of ischemia and in the nonischemic area (350%) after 15 min of ischemia and remained elevated during prolonged ischemia and reperfusion. IKK␤ activity was markedly increased in ischemic (1,800%) and nonischemic (860%) areas, and phosphorylated IB␣ levels were significantly elevated in ischemic (180%) and nonischemic (280%) areas at 5 min of ischemia and further increased after reperfusion. IB␣ levels were decreased in the ischemic (45%) and nonischemic (36%) areas after 10 min of ischemia and remained low in the ischemic area during prolonged ischemia and reperfusion. The results suggest that in vivo I/R rapidly induces IKK␤ activity and increases IB␣ phosphorylation and degradation, resulting in NF-B activation in the myocardium.
-We have demonstrated that in vitro brief ischemia activates nuclear factor (NF)-B in rat myocardium. We report in vivo ischemia-reperfusion (I/R)-induced NF-B activation, IB kinase -␤ (IKK␤) activity, and IB␣ phosphorylation and degradation in rat myocardium. Rat hearts were subjected to occlusion of the coronary artery for up to 45 min or occlusion for 15 min followed by reperfusion for up to 3 h. Cytoplasmic and nuclear proteins were isolated from ischemic and nonischemic areas of each heart. NF-B activation was increased in the ischemic area (680%) after 10 min of ischemia and in the nonischemic area (350%) after 15 min of ischemia and remained elevated during prolonged ischemia and reperfusion. IKK␤ activity was markedly increased in ischemic (1,800%) and nonischemic (860%) areas, and phosphorylated IB␣ levels were significantly elevated in ischemic (180%) and nonischemic (280%) areas at 5 min of ischemia and further increased after reperfusion. IB␣ levels were decreased in the ischemic (45%) and nonischemic (36%) areas after 10 min of ischemia and remained low in the ischemic area during prolonged ischemia and reperfusion. The results suggest that in vivo I/R rapidly induces IKK␤ activity and increases IB␣ phosphorylation and degradation, resulting in NF-B activation in the myocardium. IB␣ phosphorylation; nuclear factor-B; reperfusion INFLAMMATORY CYTOKINES, such as tumor necrosis factor-␣ (TNF-␣) and interleukin (IL)-1␤, are thought to be important in the pathogenesis of myocardial ischemia-reperfusion (I/R) injury and heart failure (4, 5, 10, 14, 19-21, 31, 42, 45) . Transgenic mice that overexpress myocardial TNF-␣ develop cardiomyopathy associated with ventricular dilation, myocyte apoptosis, transmural myocarditis, and biventricular fibrosis (4, 20, 21) . I/R induces overexpression of inflammatory cytokine and adhesion molecule genes in myocardium (15, 22, 23, 27, 41, 49) . However, the factors that regulate inflammatory cytokine gene expression in the myocardium during I/R have not been delineated.
Nuclear factor-B (NF-B) is a ubiquitous inducible transcription factor that activates a number of genes, including inflammatory cytokines (1, 2, 32) . We previously reported that in vitro I/R significantly induced NF-B activation in the myocardium (26) and that the antioxidant pyrrolidine dithiocarbamate (PDTC) (26) and adenosine (27) will prevent the ischemia-induced NF-B binding activity in isolated rat hearts. Other investigators have also shown that regulation of NF-B activation is important in cardiac responses to hypoxia and ischemia (17, 24, 38, 43, 48) . Increased NF-B binding activity, induced by hypoxia, has been reported in cultured cardiac cells (17) . Inhibition of NF-B activation by NF-B decoy oligodeoxynucleotides significantly reduced infarct size (38), improved the functional recovery (43) , and blocked intercellular adhesion molecule-1 (ICAM-1) upregulation by I/R (24) . NF-B may also be involved in the regulation of ischemic preconditioning of the heart (48). All known stimuli of NF-B activity induce the formation of reactive oxygen species (ROS). Antioxidants can block NF-B activation, suggesting that ROS may serve as a common messenger mediating the activation of NF-B (1, 2, 32).
Normally, NF-B exists in an inactive cytoplasmic form, bound to the inhibitory proteins termed IBs. The phosphorylation and degradation of IB proteins are key steps in NF-B activation, translocation into the nucleus, and stimulation of gene expression (1, 2, 32) . Recently, a high-molecular-mass kinase complex containing kinase activity specific for the phosphorylation of IB␣ Ser 32 and Ser 36 and IB␤ Ser 19 and Ser 23 has been documented, and the two main kinases in this complex, IKK␣ and IKK␤, have been cloned (9, 37, 51, 52) . NF-B-activating stimuli, such as inflammatory cytokines (TNF-␣ and IL-1␤), phorbol 12-myristate 13-acetate, and lipopolysaccharide induce IKK activity (9, 37, 51, 52) . Induction of IKK activity during myocardial I/R under in vivo conditions has not been reported. Previously, we reported (26) that brief ischemia alone rapidly induced NF-B activation concomitantly with IB␣ degradation in isolated rat hearts. We report here, for the first time to our knowledge, that in vivo ischemia rapidly induces IKK␤ activity with subsequent IB␣ phosphorylation and degradation, resulting in NF-B translocation into the nucleus and activation of gene expression in the myocardium. Early activation of NF-B by in vivo ischemia in the myocardium may be a molecular mechanism for regulating immediate-early gene expression in response to I/R stimulation. Modulation of the NF-B activation pathway could provide a means of reducing myocardial ischemic injury.
MATERIALS AND METHODS
In vivo coronary artery occlusion. Male Sprague-Dawley rats (250-300 g) were purchased from a licensed vendor and maintained in the animal care facility of East Tennessee State University in accordance with the guidelines of the "Principles of Laboratory Animal Care" and the Guide for the Care and Use of Laboratory Animals. The research protocol was reviewed and approved by the East Tennessee State University Committee on Animal Care. The rats were anesthetized with chloral hydrate (360 mg/kg ip) and ventilated with room air using a rodent ventilator (Harvard Apparatus) with a volume of ϳ2.5 ml and a rate of 60 cycles/min. The hearts were exposed through a left thoracotomy in the fourth intercostal space. A 6-0 silk ligature was placed under the left anterior descending coronary artery (LAD) and tied using a "shoestring" knot. Myocardial ischemia was confirmed by S-T segment changes and ventricular tachycardia on the electrocardiogram. The ischemic area was readily recognizable by a cyanotic appearance and a bulging region, which was carefully noted as an anatomic landmark. The chest was compressed briefly to expel intrapleural air and closed, leaving one end of the coronary suture protruding from the chest. After completion of a desired period of occlusion, the coronary artery was reperfused by pulling on the exteriorized suture to release the knot.
To study the effect of ischemia on the NF-B activation pathway in the myocardium, the coronary artery was occluded for 0, 5, 10, 15, 30, and 45 min for a group of hearts. To investigate the effect of reperfusion on the activation of NF-B in the myocardium, the hearts were subjected to 15 min of coronary occlusion followed by reperfusion for 0, 10, 15, 30, 60, and 180 min. Each time point represents five to six hearts. At the end of each time period, the hearts were immediately harvested and the blood was removed by rinsing with ice-cold PBS. The right ventricle and atria were trimmed away, and the left ventricle was divided into ischemic and nonischemic zones, on the basis of the anatomic landmarks of a cyanotic and bulging region, before it was frozen in liquid nitrogen and pulverized at liquid nitrogen temperature. The powders of the myocardial samples were extracted for nuclear and cytoplasmic proteins.
Isolation of nuclear and cytoplasmic proteins. The detailed procedures were described previously (26, 27) . Briefly, the pulverized myocardial sample was homogenized in 0.8 ml of ice-cold hypotonic buffer [10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, and 1 mM dithiothreitol (DTT), with protease inhibitors and phosphatase inhibitors]. After being centrifuged for 30 s at 2,000 rpm at 4°C, the supernatants were incubated on ice for 20 min, vortexed for 30 s after the addition of 50 l of 10% Nonidet P-40, and then centrifuged for 1 min at 10,000 rpm at 4°C in an Eppendorf centrifuge. Supernatants containing cytoplasmic proteins were collected and stored at Ϫ80°C. The pellets, after a single wash with the hypotonic buffer without Nonidet P-40, were suspended in an ice-cold hypertonic salt buffer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT, with protease inhibitors and phosphatase inhibitors), incubated on ice for 30 min, mixed frequently, and centrifuged for 15 min at 14,000 rpm at 4°C. The supernatants were collected as nuclear extracts and stored at Ϫ80°C. The concentration of total protein in the samples was determined by the Pierce bicinchoninic acid protein assay reagent (Pierce Chemical). By measuring the lactate dehydrogenase activity as an index for the cytoplasmic proteins and histone H3 proteins as a marker for the nuclear proteins in the sample preparations, we have confirmed that cytoplasmic extracts contained primarily cytoplasmic proteins while nuclear extracts consisted predominantly of nuclear proteins (27) .
Electrophoretic mobility shift assay. NF-B binding activity was determined as described previously (26, 27) in 15 l of binding reaction mixture containing 1ϫ binding buffer [50 g/ml double-stranded poly(dI-dC), 10 mM Tris ⅐ HCl (pH 7.5), 50 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, 1 mM MgCl 2 , and 10% glycerol], 15 g of nuclear proteins, and 35 fmol of double-stranded NF-B consensus oligonucleotide (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј) end labeled with [␥-
32 P]ATP (Amersham) using T4 polynucleotide kinase (Promega). After incubation at room temperature for 20 min, the binding reaction mixture was analyzed by electrophoresis on 5% nondenaturing polyacrylamide gels, and the gels were dried by Gel-Drier, scanned, and quantified by scanning densitometry (Genomic Solutions, Ann Arbor, MI). The results for each time point from each group were expressed as relative integrated intensity compared with the normal heart group measured in the same batch. We have determined the specific binding of NF-B in an isolated heart by competition experiments and confirmed that the activated NF-B in the myocardium contains p65 and p50 subunits by antibody supershift assays (26, 27) . To confirm the specific NF-B binding activity in the myocardium subjected to in vivo ischemia, competition and antibody supershift assays were performed as described previously (26, 27) .
Kinase activity assay. Approximately 200 g of cytoplasmic proteins from each sample were immunoprecipitated with 2 g of IKK␤ antibody (Santa Cruz) at 4°C for 1 h. After the addition of 10 l of protein A-agarose beads (Santa Cruz) for another 1 h at 4°C, the precipitates were collected by centrifugation at 2,500 rpm for 5 min at 4°C. The pellets were washed twice in lysis buffer (1% Nonidet P-40, 5 g/ml aprotinin, 250 mM NaCl, 5 g/ml leupeptin, 50 mM HEPES, pH 7.4, 0.5 g/ml pepstatin, 1 mM EDTA, 7.5 g/ml bestatin, 1 mM phenylmethylsulfonyl fluoride, and 5 g/ml trypsin inhibitor) and once in kinase buffer (10 mM HEPES, pH 7.4, 1 mM MnCl 2 , 5 mM MgCl 2 , 12.5 mM ␤-glycero-2-phosphate, 50 M Na 3 VO 4 , 2 mM NaF, 50 M DTT, and 10 M ATP) and resuspended in 15 l of kinase buffer. Kinase reactions were performed in the presence of 1 g of glutathione S-transferase-IB␣ substrate (Santa Cruz) and 5 Ci of [␥- 32 P]ATP (6,000 Ci/mmol; Amersham) at 30°C for 30 min. The reactions were stopped by the addition of 3ϫ Laemmli loading buffer, and the reaction mixtures were resolved on 15% polyacrylamide gels. After electrophoresis, the gels were dried by Gel-Drier and exposed to Kodak X-ray films at Ϫ70°C. The phosphorylation of substrate examined by autoradiography was quantified by scanning densitometry (Genomic Solutions). The results from each experimental group were expressed as integrated intensity relative to that of normal hearts measured with the same batch.
Western blot analysis. Cytoplasmic proteins (40 g) were mixed with 2ϫ SDS sample buffer, heated at 95°C for 5 min, and separated by SDS-polyacrylamide (12.5%) gel electrophoresis (26, 27) . The separated proteins were transferred onto Hybond enhanced chemiluminescence membranes (Amersham) and then incubated with an appropriate rabbit primary antibody [IB␣ antibody (Santa Cruz Biotechnology) and phosphorylated IB␣ antibody (New England Biolabs)] in Tris-buffered saline-0.05% Tween 20 containing 5% nonfat dry milk for 1-2 h at room temperature. After they were washed three times in Tris-buffered saline-0.05% Tween 20, the membranes were incubated with peroxidase-conjugated goat anti-rabbit IgG (Sigma Chemical) for 1 h at room temperature. After three washes in PBS, the conjugated peroxidase was visualized by enhanced chemiluminescence according to the manufacturer's instructions (Amersham). The protein signals of IB␣ or phosphorylated IB␣ were quantified by scanning densitometry (Genomic Solutions). The results from each experimental group were expressed as relative integrated intensity compared with normal and sham-operated hearts.
Statistical analysis. Values are means Ϯ SE. For tests of significance between the different time points and normal hearts, one-way ANOVA was performed. P Ͻ 0.05 was considered to be significant.
RESULTS

In vivo ischemia induces NF-B binding activity.
We previously demonstrated that ischemia alone rapidly induced myocardial NF-B activation in isolated rat hearts (26) . To investigate whether in vivo ischemia could have the same effect on myocardial NF-B activation, rat hearts were subjected to occlusion of the LAD for 0, 5, 10, 15, 30, and 45 min. At each time point, nuclear proteins were isolated from the ischemic and nonischemic zones of each heart sample and analyzed for NF-B binding activity. Ischemia alone significantly induced NF-B binding activity in ischemic and nonischemic zones of the myocardium (Fig. 1) . In the ischemic zone, the nuclear NF-B binding activity was not significantly induced by 5 min of ischemia but increased (680%) after 10 min of LAD occlusion and increased further (1,260%) after 45 min of ischemia compared with controls. In the nonischemic zone, the NF-B binding activity was present at very low levels during initial ischemia but significantly increased (64, 350, 890, and 1,130%) after 10, 15, 30, and 45 min of ischemia compared with controls. To investigate the effect of reperfusion on the activation of NF-B in the myocardium, rat hearts were subjected to LAD occlusion for 15 min and reperfusion for 15, 30, 60, and 180 min. Figure 2 shows that NF-B binding activity peaked during early reperfusion (15 and 30 min) and then gradually decreased after prolonged reperfusion (60 and 180 min) in ischemic and nonischemic zones. The data suggest that in vivo brief ischemia is a potent stimulus for the activation of NF-B, while reperfusion enhances the ischemic effects in the myocardium.
The specific binding of NF-B in ischemic myocardium was confirmed by addition of 100-fold excesses of unlabeled NF-B or activator protein (AP)-2 oligonucleotides into the electrophoretic mobility shift reaction. Unlabeled NF-B oligonucleotides competed for the binding proteins in nuclear extracts prepared from ischemic myocardium, whereas the unrelated AP-2 oligonucleotides did not (Fig. 3) . The predominant protein complex of NF-B containing p65 and p50 subunits in the ischemic myocardium was demonstrated by antibody supershift assays. Both antibodies considerably shifted the major ischemia-induced NF-B binding complex (Fig. 3) . These results confirm that the activated NF-B in ischemic rat myocardium contains subunits p65 and p50.
Ischemia induces IKK␤ activity. Recent studies have demonstrated that a multisubunit IKK complex, which contains two interactive catalytic components, IKK␣ and IKK␤, mediates specific phosphorylation of IB␣ at Ser 32 and Ser 36 , resulting in NF-B activation (9, 37, 50-53). We reasoned that the induction of NF-B activation by ischemia might be through the activation of IKK. To test this hypothesis, we examined the effects of I/R on IKK␤ activity. We chose to examine the IKK␤ activity, because IKK␤ is primarily responsible for the activation of NF-B in response to proinflammatory stimuli, whereas IKK␣ is essential for keratinocyte differentiation (8, (28) (29) (30) . Figure 4 shows that IKK␤ activity was very low in normal and sham-operated control hearts but markedly increased in ischemic (1,800%) and nonischemic (860%) areas after 5 min of ischemia. The enhanced IKK␤ activity persisted up to 45 min of ischemia. After slightly decreasing after 15 min of reperfusion, the IKK␤ activity further increased in ischemic (3,800%) and nonischemic (4,800%) areas at 30 min of reperfusion. The data suggest that I/R- induced NF-B activation is associated with increasing IKK␤ activity in the myocardium.
Ischemia rapidly induces myocardial IB␣ phosphorylation and degradation. We previously reported that in vitro brief ischemia markedly decreased IB␣ protein levels in the cytoplasm of isolated rat hearts and that the antioxidant PDTC (26) or adenosine (27) prevented ischemia-induced decreases in the cytoplasmic IB␣ protein levels, thereby inhibiting NF-B activation. Because IKK␤ activity was rapidly induced by I/R (Fig. 4) , we further investigated whether I/R will result in the cytoplasmic IB␣ phosphorylation and degradation. The levels of phosphorylated IB␣ (phospho-IB␣) and IB␣ proteins in the cytoplasm during in vivo myocardial I/R were examined by Western blots. Figure 5 shows that the levels of phosphorylated IB␣ were very low in the normal and sham-operated controls but significantly increased in ischemic (180%) and nonischemic (280%) areas at 5 min of ischemia. The elevated phosphorylated IB␣ persisted up to 45 min of ischemia in ischemic and nonischemic areas. Reperfusion further increased the levels of phosphorylated IB␣ in ischemic and nonischemic areas.
As shown in Fig. 6 , the levels of IB␣ proteins in the cytoplasm were slightly decreased after 5 min of ischemia and reduced by 45% in the ischemic zone after 10 min of ischemia, and the decreased IB␣ levels persisted up to 30 min of ischemia. The IB␣ levels returned to control levels after 45 min of ischemia. In the nonischemic zone, IB␣ protein levels were also decreased 36% after 10 min of ischemia but returned to control levels by 15 min of ischemia. We also investigated the effects of reperfusion on the levels of cytoplasmic IB␣ protein. Figure 7 shows that the levels of Fig. 2 . Reperfusion (R) after ischemia in vivo increased NF-B binding activity in rat hearts. Rat hearts were subjected to occlusion of the LAD for 15 min followed by reperfusion for 15, 30, 60, and 180 min. At each time point, hearts were harvested, and ischemic (I) and nonischemic (N) areas were separated. Nuclear extracts were prepared from each sample, and NF-B binding activity was analyzed. Tissue samples from normal and sham groups were taken from the same regions as those from ischemic hearts and served as controls. Values are means Ϯ SE of 5-6 hearts for each time point. *P Ͻ 0.05 compared with controls. Top: representative blot from electrophoretic mobility shift assay; NF-B (2 bands) and nonspecific bands are labeled. Free probe is not shown. IB␣ proteins were decreased in the ischemic zone after 30 and 60 min of reperfusion but returned to control levels after reperfusion for 180 min. There was no significant change in the IB␣ levels in the nonischemic zone during reperfusion (Fig. 7) . The data suggest that NF-B activation in the myocardium induced by in vivo ischemia is concomitant with increases in IKK␤ activity and cytoplasmic IB␣ phosphorylation and degradation.
DISCUSSION
A significant finding of this study is that brief in vivo ischemia is a potent stimulus that rapidly induces IKK␤ activity and increases IB␣ phosphorylation and degradation in the cytoplasm, resulting in NF-B translocation and activation in the nucleus of rat myocardium. Reperfusion enhances the ischemic effects.
The activation of NF-B is thought to be critical in the stimulation of inducible gene expression, including inflammatory cytokines (TNF-␣, IL-1, IL-2, IL-6, IL-8, and interferon-␥) and adhesion molecules (vascular cell adhesion molecule-1, ICAM-1, and E-selectin) (1, 2, 32) . The expression of these genes has been demonstrated to be significantly increased after I/R in the myocardium (15, 19, 21, 22, 27, 31, 39, 41) , and these genes have been suggested to be factors that might be involved in the depression of cardiac function, mediation of remodeling, and cardiac hypertrophy (4, 5, 10, 19-21, 31, 41) . Specific blockade of NF-B activation with NF-B decoy oligodeoxynucleotides has been shown to reduce infarct size and improve recovery of cardiac function after I/R insult, which correlated with the inhibition of inflammatory cytokine gene expression in the myocardium (38, 43). These data suggest a cause-and-effect relationship between NF-B activation and myocardial I/R injury. The present study suggests that early activation of NF-B after a brief ischemia may be a molecular mechanism for regulating inflammatory cytokine gene expression in the myocardium.
Our results show that NF-B activation after I/R was induced first in the ischemic area, increased in the nonischemic area, and then gradually decreased during reperfusion up to 3 h. These results were in contrast to an earlier study (6), using proteins from whole tissue homogenates, which reported that NF-B activation was not induced in the nonischemic area and that NF-B activation in the ischemic area increased biphasically with peaks at 15 min and 3 h of reperfusion. The differences may be due to the use of different protein extracts to analyze NF-B activation. In the present study, we used nuclear extracts for the analysis of nuclear NF-B binding activity. The detection of NF-B binding changes using whole tissue homogenates will not truly reflect NF-B activation and translocation into the nucleus. This is not only because NF-B normally exists in the cytoplasm as an inactive Fig. 6 . In vivo ischemia transiently decreases cytoplasmic IB␣ protein in the myocardium. Rat hearts were subjected to occlusion of the LAD for 5, 10, 15, 30, and 45 min. At each time point, hearts were harvested, and ischemic and nonischemic areas were separated. Cytoplasmic extracts were prepared from each sample, and levels of cytoplasmic IB␣ protein were analyzed by Western blot. Tissue samples from normal and sham groups were taken from the same regions as those from ischemic hearts and served as controls. Values are means Ϯ SE of 5-6 hearts for each time point. *P Ͻ 0.05 compared with controls. Top: representative Western blot; IB␣ band is labeled. Fig. 5 . Ischemia-reperfusion in vivo increased levels of phosphorylated (phospho) IB␣ in cytoplasm of rat hearts. Rat hearts were subjected to occlusion of the LAD for 5, 10, 15, 30, and 45 min or 15 min of ischemia followed by reperfusion for 15 and 30 min. At each time point, hearts were harvested, and ischemic and nonischemic areas were separated. Cytoplasmic extracts were prepared from each sample, and levels of phosphorylated IB␣ protein were analyzed by Western blot. Tissue samples from normal and sham groups were taken from the same regions as those from ischemic hearts and served as controls. Values are means Ϯ SE of 5 hearts for each time point. *P Ͻ 0.05 compared with controls. Top: representative Western blot; phosphorylated IB␣ band is labeled.
form but also because the levels of NF-B in the cytoplasm may increase due to the NF-B/IB autoregulatory feedback mechanism (7, 44) .
Consistent with our observation that NF-B activation was induced in the nonischemic zone during I/R, it was recently reported that in vivo I/R significantly increased P-selectin, E-selectin, and ICAM-1 production on endothelial cells not only in the ischemic area but also in the nonischemic area in a murine model of myocardial I/R (16) . Also, in a rat model of myocardial infarction, gene expression of TNF-␣, IL-1␤, and IL-6 was significantly upregulated in the nonischemic region after coronary occlusion (41) . NF-B activation in the nonischemic area may be responsible for the increased expression of these genes in the nonischemic region after coronary occlusion. Several factors may account for this observation. First, ROS that are rapidly generated during I/R (3, 12, 40, 46, 47) may be responsible for the activation of NF-B in the nonischemic area. A significant increase in the levels of hydroxyl radicals in the coronary vein has been observed during ischemia for 1-10 min (40) . A membrane-permeable free radical scavenger, tempol, has been shown to significantly reduce infarct size/area at risk (33) , suggesting that the ROS-NF-B activation pathway plays an important role in the myocardial I/R injury. Second, TNF-␣, which is preformed in mast cells and interstitial cells in the heart (11, 35) , may also contribute to activation of NF-B, because TNF-␣ was released when mast cells degranulate during myocardial I/R. Finally, resident macrophages in the heart (18, 36) and cardiac myocytes are a major source of inflammatory cytokines, including TNF-␣ (13, 34) . The locally produced TNF-␣ will be a potent factor for the activation of NF-B during myocardial I/R.
We previously demonstrated that in vitro ischemia induces NF-B activation concomitantly with cytoplasmic IB␣ degradation in isolated rat heart (26) . Prevention of cytoplasmic IB␣ degradation by an antioxidant, e.g., PDTC (26) , or adenosine (27) will inhibit NF-B activation induced by ischemia, suggesting that ischemia-induced NF-B activation in the myocardium requires the cytoplasmic IB␣ phosphorylation and degradation. Recently, a multisubunit IB kinase (IKK) has been identified to be responsible for the inducible phosphorylation of IB␣ at Ser 32 and Ser 36 , which appears to be the critical step in NF-B activation induced by most stimuli. To understand the signaling pathway of ischemia-induced NF-B in the myocardium, we analyzed IKK␤ activity and the cytoplasmic phosphorylated IB␣ levels during myocardial I/R. A brief ischemia markedly induced IKK␤ activity and increased phosphorylated IB␣ levels, which is consistent with the data showing that IB␣ levels in the cytoplasm markedly decreased after 10 min of ischemia (Figs. 5 and 6 ). The results suggest that ischemia-induced IKK␤ activity leads to IB␣ phosphorylation and degradation, with subsequent activation of NF-B. We have noted that the levels of IKK␤ activity were similar between 10 min of ischemia and 15 min of reperfusion. This may be due to the IKK autofeedback regulation mechanisms that reduce its activity; meanwhile, the continuous reperfusion further stimulates the IKK␤ activity.
IKK contains two catalytic subunits, IKK␣ and IKK␤, both of which phosphorylate IB␣ at sites phosphorylated in vivo. We did not analyze IKK␣ activity, because it has been demonstrated by gene knockout studies that IKK␤ is primarily responsible for the activation of NF-B in response to proinflammatory stimuli, whereas IKK␣ is essential for keratinocyte differentiation (8, (28) (29) (30) . We also noted that IKK␤ activity and the levels of phosphorylated IB␣ in ischemic and nonischemic zones were markedly increased during prolonged I/R. This finding may explain why NF-B activation persisted during myocardial I/R, even if cytoplasmic IB␣ proteins returned to control levels. In the NF-B activation pathway, IKK autophosphorylation is an important feedback autoregulatory mechanism for the restriction of NF-B activation, since persistent NF-B activation can result in detrimental conditions due to excessive inflammatory cytokine production (51) . In this model, once activated, IKK will autophosphorylate its COOH-terminal region, and the conformation of the kinase domain will then be changed, resulting in decreased IKK activity (51) . This transient IKK activation and negative-feedback mechanism is very critical in limiting IKK activity, because small decreases in IKK activity will result in large Fig. 7 . Reperfusion after in vivo ischemia decreased IB␣ protein levels in the ischemic zone, but not in the nonischemic zone, of rat myocardium. Rat hearts were subjected to occlusion of the LAD for 15 min followed by reperfusion for 10, 15, 30, 60, and 180 min. At each time point, hearts were harvested, and ischemic and nonischemic areas were separated. Cytoplasmic extracts were prepared from each sample, and levels of cytoplasmic IB␣ protein were analyzed by Western blot. Tissue samples from normal and sham groups were taken from the same regions as those from ischemic hearts and served as controls. Values are means Ϯ SE of 5 hearts for each time point. *P Ͻ 0.05 compared with controls. Top: representative Western blot; IB␣ band is labeled. decreases in IB degradation and NF-B activation (50) . A significant finding in the present study is that persistent IKK␤ activity during myocardial I/R could be an important molecular mechanism that causes overproduction of inflammatory cytokines through prolonged NF-B activation.
We have observed that 10 min of ischemia significantly increased phosphorylated IB␣ levels and reduced IB␣ levels in ischemic and nonischemic areas. NF-B activation was significantly increased in the ischemic area and enhanced (64%) in the nonischemic area compared with sham controls. The data may suggest that the degree of NF-B activation could be different in response to various stimuli. NF-B activation in the ischemic area could be induced by ROS generated during ischemia, while it may be caused by inflammatory cytokine (TNF-␣) released from degraduated mast cells and macrophages in the nonischemic area. In addition, cells in the ischemic area are more stressed than those in the nonischemic area, which may be an additional factor for rapidly increasing NF-B activation.
We have observed that the cytoplasmic IB␣ protein levels, after rapidly decreasing during early ischemia, gradually returned to control levels after prolonged ischemia in isolated hearts in vitro (26, 27) . This may be due to NF-B-IB␣ feedback autoregulation (7, 44) . In this model, IB␣ controls NF-B activation, while activated NF-B in turn promotes IB␣ gene expression (7, 25) . The newly synthesized IB␣ rapidly replenishes the depleted pool of IB␣ protein in the cytoplasm to reestablish inactive cytoplasmic NF-B complexes (7, 44) . In the present study, the levels of cytoplasmic IB␣ protein were decreased in the ischemic zone during ischemia (10-30 min) and after reperfusion (up to 60 min) but nearly returned to control levels after 180 min of reperfusion. In the nonischemic zone, the cytoplasmic IB␣ protein levels, however, were reduced only after 10 min of ischemia but were restored after the prolonged ischemia and reperfusion. This may be due to a difference in the NF-B-IB␣ feedback autoregulation mechanism in the ischemic and nonischemic zones, and it could be dependent on the tissue conditions during myocardial I/R. For example, there may be more damaged cells in the ischemic zone, which retards the IB␣ protein feedback autoregulation loop.
In summary, the present study suggests that in vivo brief ischemia rapidly induces IKK␤ activity concomitantly with increases in the cytoplasmic IB␣ phosphorylation and degradation, resulting in increasing NF-B binding activity in the nucleus of the rat myocardium.
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